Synthetic Genomics, Venter Institute Form Vaccines Firm | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and the non-profit J. Craig Venter Institute today announced that they have formed a new company, called Synthetic Genomics Vaccines, focused on genomic-based vaccines.

The partners, both based in La Jolla, Calif., and co-founded by Craig Venter, said they will develop next-generation vaccines using JCVI's genomic sequencing and synthetic genomic research expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.